This article was originally published in The Tan Sheet
Executive SummaryNovogen's red clover isoflavone-containing supplement "is a natural alternative for minimizing vaginal dryness in healthy, postmenopausal women," Malcolm Whitehead, King's College Hospital, London, et al., told attendees at the British Menopause Society meeting July 6. Prospective, randomized, double-blind, placebo-controlled crossover study involved 29 postmenopausal women ages 45-65 who took either Promensil or placebo daily for eight weeks, then underwent a wash-out period and switched to eight weeks of the opposite therapy. Whitehead et al. used vaginal smears to measure vaginal maturation index. Treatment arm showed "significant improvement in VMI compared to placebo" and researchers did not find endometrial thickening, which can occur with hormone replacement therapy...
You may also be interested in...
Grail announced it will enroll about 6,200 people in an interventional, multi-center study evaluating its multi-cancer early-detection blood test. This is the first time health care providers will use this test to help guide patient care.
As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.